Advancis Shares Drop 15% After FDA Denies Application for Antibiotic
495636
Shares of Advancis Pharmaceutical Corp. slid nearly 15 percent yesterday after the company said that the Food and Drug Administration had not accepted its application for a once-a-day version of the antibiotic amoxicillin.
372533
By Tricia Bishop, The Baltimore Sun  Dec. 17--When a judge ruled this summer that Advancis Pharmaceutical Corp. had to change its name because it was too similar to another company's, it was a significant setback. But it offered a chance for the Germantown drugmaker to do better.
667257
The Vienna, Va.-based developer of treatments for cancer and infectious diseases said its loss fell to 1 cent per share versus 3 cents per share in the same quarter a year earlier, according to an SEC filing.
105959
Shares of the Medicines Co.  fell 10 percent on Monday after the U.S. Congress failed to enact a bill that would have helped the company's bid to extend a patent on its flagship drug Angiomax, a blood thinner.
380561
Shares of Merck &amp; Co. plunged almost 10 percent yesterday after a media report said that documents show the pharmaceutical giant hid or denied
166901
Cellegy Pharmaceuticals Inc. shares lost nearly half their value in Monday trading after the Food and Drug Administration rejected the company&#39;s ointment for treating pain from chronic anal fissure.
727266
Shares of drug distributor Henry  Schein Inc. HSIC.O fell nearly 3 percent before the bell on  Wednesday after trading resumed a day after news that a major  flu vaccine it distributes will not be available this year.
398593
U.S. regulators on Friday turned  down AstraZeneca Plc's  AZN.L AZN.N anti-clotting drug  Exanta, following the advice of an advisory panel on which some  members had voiced doubt about the drug's safety and  effectiveness.
479311
Shares in AstraZeneca Plc fell as much  as 10 percent on Friday after regulators in the United States  and Europe raised safety concerns about the Anglo-Swedish drug  maker's anti-cholesterol treatment Crestor.
73972
Shares of Syneron Medical Ltd., a maker of cosmetic medical devices, plunged 20 percent Tuesday morning following regulators&#39; rejection of its application for a cellulite-smoothing device.
533107
Idenix Pharmaceuticals Inc., a Cambridge-based drug company, said yesterday that federal regulators suspended testing of its hepatitis C drug, resulting in a 38 percent drop in the company's stock.
167015
PARIS/LONDON  - Sanofi-Aventis shares rose on   Friday after a U.S. judge blocked further sales of generic   Plavix, but gains were capped as it warned cheap supplies of   the blood-thinner already in the market would hit 2006 profits.
335721
Shares of large U.S. and European drug  makers fell on Thursday after a prominent cardiologist  questioned the safety of new arthritis drugs and the  performance of U.S. regulators in monitoring drug safety.
750028
Shares in Schering dropped on Friday  after the German drugmaker said U.S. regulators needed more  information to approve its key Bonefos drug for use in  preventing bone tumors in breast cancer patients.
353033
Shares plunge after company says its vein graft treatment failed to show benefit in late-stage test. CHICAGO  - Biotechnology company Corgentech Inc.
585919
The company withdrew its application to gain federal approval for a weight loss drug after a meeting at which government advisers rejected the treatment on safety grounds.
469532
Judge is expected to decline motion to block a generic version of Pfizer&#39;s $3B epilepsy drug. CHICAGO  - Pfizer Inc. shares tumbled Thursday as investors worried a federal judge will refuse the company&#39;s